Descripción de la empresa
PACS Group, Inc. operates through its subsidiaries as a provider of skilled nursing facilities, assisted living facilities, senior care, and independent living facilities within the United States, while also engaging in the acquisition, ownership, and leasing of healthcare-related properties. This business model positions the company squarely within the Healthcare sector, specifically under the Medical Care Facilities industry, where it delivers essential services to the aging population and manages significant real estate assets. The enterprise demonstrates substantial scale with a market capitalization of $4.81 billion and reported annual revenue (TTM) of $5.29 billion, supported by a workforce of 47,455 employees. These valuation and revenue figures indicate that PACS Group is a major player in the senior care landscape, reflecting a robust operational footprint that commands significant market attention despite the capital-intensive nature of healthcare real estate and facility management.
Salud financiera
The company reported a total revenue of $5.29 billion over the trailing twelve months, generating a net income of $191.54 million and an EBITDA of $365.26 million. The substantial gap between the $5.29 billion in revenue and the $191.54 million in net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume approximately 96.4% of total revenue before interest and taxes. Free cash flow stands at $241.90 million, which signifies the company's ability to generate liquidity after capital expenditures, providing financial flexibility for debt servicing, potential acquisitions, or operational improvements without relying solely on external financing. The company maintains a cash balance of $197.02 million against total debt of $3.60 billion, resulting in a debt-to-equity ratio of 377.77, which characterizes a highly leveraged balance sheet typical of asset-heavy healthcare real estate firms. Current liquidity is assessed via a current ratio of 1.07, indicating that current assets slightly exceed current liabilities, suggesting a tight but manageable short-term liquidity position. Return on Equity is reported at 23.0%, while Return on Assets is 3.6%; these metrics reveal that management is highly effective at generating returns for shareholders relative to equity invested, yet the return on assets is moderated by the heavy asset base and high leverage inherent in the facility ownership model.
Evaluación de valoración
Valuation multiples for PACS Group show a P/E Ratio (TTM) of 25.07 and a Forward P/E of 12.96. The significant difference between the trailing and forward P/E multiples implies that the market expects a substantial increase in earnings growth in the coming years to justify the lower forward multiple, suggesting analysts anticipate a sharp improvement in profitability. The price-to-book ratio is 5.06, indicating that the market values the company at a significant premium over its book value, likely reflecting the intangible value of its brand, long-term contracts, and the quality of its senior care assets. Alternative valuation metrics include a price-to-sales ratio of 0.91 and an EV/EBITDA of 22.49; these figures suggest that while the stock trades at less than one dollar of sales per share, the enterprise value relative to earnings remains elevated due to the high debt load included in the enterprise value calculation. Price momentum is observed within a 52-week range defined by a high of $43.08 and a low of $7.50, meaning the current market price sits significantly closer to the high end of this historical range, reflecting recent bullish sentiment. The beta value is listed as N/A, which precludes a standard volatility assessment relative to the broader market, though the high leverage noted in the financial health section generally implies elevated price sensitivity to interest rate fluctuations.
Growth & Income
Growth dynamics are highlighted by a revenue growth rate of 12.4% year-over-year and an earnings growth rate of 57.2% year-over-year. The earnings growth rate is substantially faster than the revenue growth rate, implying that the company is achieving significant operational leverage, likely through margin expansion or efficiency gains that allow profits to outpace top-line sales growth. Regarding income distribution, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. This lack of dividend payments indicates that the company chooses to reinvest all generated earnings into business expansion, facility upgrades, or debt reduction rather than distributing cash to shareholders. Consequently, the overall growth and income profile is characterized by aggressive capital deployment for expansion rather than current income generation, a strategy common in high-growth, high-leverage healthcare real estate sectors where capital allocation is prioritized over immediate shareholder payouts.